Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

OMI vs SYK

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
OMI
Owens & Minor, Inc.

Medical - Distribution

HealthcareNYSE • US
Market Cap$171M
5Y Perf.-71.8%
SYK
Stryker Corporation

Medical - Devices

HealthcareNYSE • US
Market Cap$113.08B
5Y Perf.+88.8%

OMI vs SYK — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
OMI logoOMI
SYK logoSYK
IndustryMedical - DistributionMedical - Devices
Market Cap$171M$113.08B
Revenue (TTM)$2.76B$25.12B
Net Income (TTM)$-1.10B$3.25B
Gross Margin63.5%
Operating Margin1.0%22.4%
Forward P/E2.3x19.7x
Total Debt$320M$14.86B
Cash & Equiv.$282M$4.01B

OMI vs SYKLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

OMI
SYK
StockMay 20Feb 26Return
Owens & Minor, Inc. (OMI)10028.2-71.8%
Stryker Corporation (SYK)100188.8+88.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: OMI vs SYK

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: SYK leads in 6 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Owens & Minor, Inc. is the stronger pick specifically for valuation and capital efficiency. As sector peers, any of these can serve as alternatives in the same allocation.
OMI
Owens & Minor, Inc.
The Value Play

OMI is the clearest fit if your priority is value.

  • Lower P/E (2.3x vs 19.7x)
Best for: value
SYK
Stryker Corporation
The Income Pick

SYK carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 34 yrs, beta 0.55, yield 1.1%
  • Rev growth 11.2%, EPS growth 8.2%, 3Y rev CAGR 10.8%
  • 191.1% 10Y total return vs OMI's -86.1%
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthSYK logoSYK11.2% revenue growth vs OMI's -74.2%
ValueOMI logoOMILower P/E (2.3x vs 19.7x)
Quality / MarginsSYK logoSYK12.9% margin vs OMI's -39.8%
Stability / SafetySYK logoSYKBeta 0.55 vs OMI's 1.44
DividendsSYK logoSYK1.1% yield; 34-year raise streak; the other pay no meaningful dividend
Momentum (1Y)SYK logoSYK-21.7% vs OMI's -72.6%
Efficiency (ROA)SYK logoSYK6.9% ROA vs OMI's -44.9%, ROIC 11.4% vs 1.8%

OMI vs SYK — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

OMIOwens & Minor, Inc.
FY 2025
Diabetes Product
56.9%$783M
Product and Service, Other
20.9%$288M
Wound Care
13.7%$189M
Urology
8.4%$116M
SYKStryker Corporation
FY 2025
MedSurg
62.3%$15.6B
Orthopaedics
37.7%$9.5B

OMI vs SYK — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLSYKLAGGINGOMI

Income & Cash Flow (Last 12 Months)

SYK leads this category, winning 4 of 5 comparable metrics.

SYK is the larger business by revenue, generating $25.1B annually — 9.1x OMI's $2.8B. SYK is the more profitable business, keeping 12.9% of every revenue dollar as net income compared to OMI's -39.8%. On growth, SYK holds the edge at +11.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricOMI logoOMIOwens & Minor, In…SYK logoSYKStryker Corporati…
RevenueTrailing 12 months$2.8B$25.1B
EBITDAEarnings before interest/tax$277M$6.3B
Net IncomeAfter-tax profit-$1.1B$3.2B
Free Cash FlowCash after capex-$353M$4.3B
Gross MarginGross profit ÷ Revenue+63.5%
Operating MarginEBIT ÷ Revenue+1.0%+22.4%
Net MarginNet income ÷ Revenue-39.8%+12.9%
FCF MarginFCF ÷ Revenue-12.8%+17.1%
Rev. Growth (YoY)Latest quarter vs prior year-146.3%+11.4%
EPS Growth (YoY)Latest quarter vs prior year+4.5%+56.0%
SYK leads this category, winning 4 of 5 comparable metrics.

Valuation Metrics

OMI leads this category, winning 4 of 4 comparable metrics.

On an enterprise value basis, OMI's 1.7x EV/EBITDA is more attractive than SYK's 20.4x.

MetricOMI logoOMIOwens & Minor, In…SYK logoSYKStryker Corporati…
Market CapShares × price$171M$113.1B
Enterprise ValueMkt cap + debt − cash$209M$123.9B
Trailing P/EPrice ÷ TTM EPS-0.16x35.15x
Forward P/EPrice ÷ next-FY EPS est.2.31x19.69x
PEG RatioP/E ÷ EPS growth rate2.36x
EV / EBITDAEnterprise value multiple1.70x20.38x
Price / SalesMarket cap ÷ Revenue0.06x4.50x
Price / BookPrice ÷ Book value/share5.03x
Price / FCFMarket cap ÷ FCF26.40x
OMI leads this category, winning 4 of 4 comparable metrics.

Profitability & Efficiency

SYK leads this category, winning 6 of 8 comparable metrics.

SYK delivers a 15.0% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $-21 for OMI. On the Piotroski fundamental quality scale (0–9), SYK scores 6/9 vs OMI's 2/9, reflecting solid financial health.

MetricOMI logoOMIOwens & Minor, In…SYK logoSYKStryker Corporati…
ROE (TTM)Return on equity-21.1%+15.0%
ROA (TTM)Return on assets-44.9%+6.9%
ROICReturn on invested capital+1.8%+11.4%
ROCEReturn on capital employed+1.3%+13.0%
Piotroski ScoreFundamental quality 0–926
Debt / EquityFinancial leverage0.66x
Net DebtTotal debt minus cash$38M$10.8B
Cash & Equiv.Liquid assets$282M$4.0B
Total DebtShort + long-term debt$320M$14.9B
Interest CoverageEBIT ÷ Interest expense-0.12x6.72x
SYK leads this category, winning 6 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

SYK leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in SYK five years ago would be worth $12,274 today (with dividends reinvested), compared to $697 for OMI. Over the past 12 months, SYK leads with a -21.7% total return vs OMI's -72.6%. The 3-year compound annual growth rate (CAGR) favors SYK at 2.3% vs OMI's -50.6% — a key indicator of consistent wealth creation.

MetricOMI logoOMIOwens & Minor, In…SYK logoSYKStryker Corporati…
YTD ReturnYear-to-date-3.4%-14.9%
1-Year ReturnPast 12 months-72.6%-21.7%
3-Year ReturnCumulative with dividends-88.0%+7.2%
5-Year ReturnCumulative with dividends-93.0%+22.7%
10-Year ReturnCumulative with dividends-86.1%+191.1%
CAGR (3Y)Annualised 3-year return-50.6%+2.3%
SYK leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

SYK leads this category, winning 2 of 2 comparable metrics.

SYK is the less volatile stock with a 0.55 beta — it tends to amplify market swings less than OMI's 1.44 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SYK currently trades 72.9% from its 52-week high vs OMI's 23.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricOMI logoOMIOwens & Minor, In…SYK logoSYKStryker Corporati…
Beta (5Y)Sensitivity to S&P 5001.44x0.55x
52-Week HighHighest price in past year$9.55$404.87
52-Week LowLowest price in past year$1.84$290.17
% of 52W HighCurrent price vs 52-week peak+23.5%+72.9%
RSI (14)Momentum oscillator 0–10046.520.2
Avg Volume (50D)Average daily shares traded690K2.0M
SYK leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

SYK leads this category, winning 1 of 1 comparable metric.

Wall Street rates OMI as "Hold" and SYK as "Buy". Consensus price targets imply 78.6% upside for OMI (target: $4) vs 36.7% for SYK (target: $404). SYK is the only dividend payer here at 1.14% yield — a key consideration for income-focused portfolios.

MetricOMI logoOMIOwens & Minor, In…SYK logoSYKStryker Corporati…
Analyst RatingConsensus buy/hold/sellHoldBuy
Price TargetConsensus 12-month target$4.00$403.69
# AnalystsCovering analysts1050
Dividend YieldAnnual dividend ÷ price+1.1%
Dividend StreakConsecutive years of raises034
Dividend / ShareAnnual DPS$3.36
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%
SYK leads this category, winning 1 of 1 comparable metric.
Key Takeaway

SYK leads in 5 of 6 categories (Income & Cash Flow, Profitability & Efficiency). OMI leads in 1 (Valuation Metrics).

Best OverallStryker Corporation (SYK)Leads 5 of 6 categories
Loading custom metrics...

OMI vs SYK: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is OMI or SYK a better buy right now?

For growth investors, Stryker Corporation (SYK) is the stronger pick with 11.

2% revenue growth year-over-year, versus -74. 2% for Owens & Minor, Inc. (OMI). Stryker Corporation (SYK) offers the better valuation at 35. 1x trailing P/E (19. 7x forward), making it the more compelling value choice. Analysts rate Stryker Corporation (SYK) a "Buy" — based on 50 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — OMI or SYK?

On forward P/E, Owens & Minor, Inc.

is actually cheaper at 2. 3x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — OMI or SYK?

Over the past 5 years, Stryker Corporation (SYK) delivered a total return of +22.

7%, compared to -93. 0% for Owens & Minor, Inc. (OMI). Over 10 years, the gap is even starker: SYK returned +191. 1% versus OMI's -86. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — OMI or SYK?

By beta (market sensitivity over 5 years), Stryker Corporation (SYK) is the lower-risk stock at 0.

55β versus Owens & Minor, Inc. 's 1. 44β — meaning OMI is approximately 164% more volatile than SYK relative to the S&P 500.

05

Which is growing faster — OMI or SYK?

By revenue growth (latest reported year), Stryker Corporation (SYK) is pulling ahead at 11.

2% versus -74. 2% for Owens & Minor, Inc. (OMI). On earnings-per-share growth, the picture is similar: Stryker Corporation grew EPS 8. 2% year-over-year, compared to -201. 1% for Owens & Minor, Inc.. Over a 3-year CAGR, SYK leads at 10. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — OMI or SYK?

Stryker Corporation (SYK) is the more profitable company, earning 12.

9% net margin versus -39. 8% for Owens & Minor, Inc. — meaning it keeps 12. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SYK leads at 19. 5% versus 1. 0% for OMI. At the gross margin level — before operating expenses — SYK leads at 64. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is OMI or SYK more undervalued right now?

On forward earnings alone, Owens & Minor, Inc.

(OMI) trades at 2. 3x forward P/E versus 19. 7x for Stryker Corporation — 17. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for OMI: 78. 6% to $4. 00.

08

Which pays a better dividend — OMI or SYK?

In this comparison, SYK (1.

1% yield) pays a dividend. OMI does not pay a meaningful dividend and should not be held primarily for income.

09

Is OMI or SYK better for a retirement portfolio?

For long-horizon retirement investors, Stryker Corporation (SYK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

55), 1. 1% yield, +191. 1% 10Y return). Both have compounded well over 10 years (SYK: +191. 1%, OMI: -86. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between OMI and SYK?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

SYK pays a dividend while OMI does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

OMI

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

SYK

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 7%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform OMI and SYK on the metrics below

Revenue Growth>
%
(OMI: -146.3% · SYK: 11.4%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.